Stocks and InvestingStocks and Investing
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024
Mon, June 17, 2024
Fri, June 14, 2024

Kostas Biliouris Maintained (SRPT) at Buy and Held Target at $170 on, Jun 14th, 2024


Published on 2024-10-28 11:57:28 - WOPRAI, Kostas Biliouris
  Print publication without navigation


Kostas Biliouris of BMO Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $170 on, Jun 14th, 2024.

Kostas has made no other calls on SRPT in the last 4 months.



There are 12 other peers that have a rating on SRPT. Out of the 12 peers that are also analyzing SRPT, 3 agree with Kostas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $142 on, Tuesday, May 28th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $128 on, Thursday, May 2nd, 2024
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Hold with Increased Target to $138 on, Tuesday, February 20th, 2024


These are the ratings of the 9 analyists that currently disagree with Kostas


  • Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $157 on, Friday, May 31st, 2024
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $166 on, Monday, May 20th, 2024
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $167 on, Friday, March 1st, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $172 on, Thursday, February 29th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $185 on, Thursday, February 29th, 2024
  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $224 on, Tuesday, February 20th, 2024